Chesnara Plc: Fourth acquisition in two years
12 November 2026
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is at the forefront of innovation in the biotechnology sector, with a focus on developing novel therapeutics for rare endocrine diseases..
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) presents a compelling opportunity for investors intrigued by the biotechnology sector’s potential for high returns. With a market capitalization of..
Beam Therapeutics Inc. (NASDAQ: BEAM) is capturing investor attention with its impressive potential upside of 130.75%, as indicated by the average analyst target price of $50.53...
Alignment Healthcare, Inc. (NASDAQ: ALHC) is capturing the attention of investors with its promising potential for growth. The company, operating in the healthcare plans industry, specializes..
CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector specializing in medical devices, currently presents an intriguing opportunity for investors. With its stock price..
Investors eyeing the healthcare sector may find LeMaitre Vascular, Inc. (NASDAQ: LMAT) an intriguing prospect, especially considering its robust 15.70% revenue growth and the potential 3.86%..
Investors seeking exposure in the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing proposition, especially given its nearly 48% potential upside according to..
Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology arena, is captivating investor attention with its robust revenue growth and intriguing pipeline of innovative therapies...
Certara, Inc. (NASDAQ: CERT) is capturing investor attention with its potential for significant upside, despite current market challenges. Specializing in healthcare information services, Certara provides cutting-edge..
Apogee Therapeutics, Inc. (NASDAQ: APGE) is making waves in the biotechnology sector with its promising pipeline of novel biologics targeting a range of inflammatory and immunological..
Premier, Inc. (NASDAQ: PINC), a major player in the healthcare information services industry, presents a unique investment case for those interested in the healthcare sector. With..
MoonLake Immunotherapeutics (NASDAQ: MLTX), a biotechnology company at the forefront of developing innovative therapies for inflammatory skin and joint diseases, has captured significant attention with its..
Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company headquartered in Suzhou, China, has recently caught the attention of investors, thanks to its impressive growth potential...
For investors with an eye on the biotechnology sector, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presents a compelling opportunity. With a market capitalization of $3.84 billion, Ligand..
Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biopharmaceutical company, stands out in the biotechnology sector with its promising pipeline focused on neurological and psychiatric disorders. With..
HUTCHMED (China) Limited (HCM) is a healthcare powerhouse within the specialty and generic drug manufacturing sector, renowned for its pioneering work in developing targeted therapeutics and..
Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline of therapeutics and..
DENTSPLY SIRONA Inc. (XRAY), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents an intriguing investment opportunity. Despite recent..
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is a key player in the biotechnology sector, dedicated to developing treatments for rare diseases. With its headquarters in Princeton, New..
